The Cannabist Company Holdings Inc. (CBST.NE)
CAD 0.08
(-6.25%)
CAD 0.08
(-6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -51.3 Million USD | 110.98% |
| 2022 | -416.24 Million USD | -3152.28% |
| 2021 | -63.69 Million USD | 142.51% |
| 2020 | -32.08 Million USD | 42.26% |
| 2019 | -95.21 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.86 Million USD | 97.08% |
| 2024 Q2 | 21.73 Million USD | 1330.75% |
| 2023 Q4 | 25.59 Million USD | 1718.02% |
| 2023 FY | - USD | 110.98% |
| 2023 Q3 | -1.58 Million USD | -110.84% |
| 2023 Q2 | 14.59 Million USD | 104.71% |
| 2023 Q1 | 7.13 Million USD | 101.98% |
| 2022 Q2 | -9.77 Million USD | -244.5% |
| 2022 Q1 | 6.76 Million USD | -41.41% |
| 2022 FY | - USD | -3152.28% |
| 2022 Q4 | -360.75 Million USD | -960.02% |
| 2022 Q3 | -34.03 Million USD | -248.06% |
| 2021 FY | - USD | 142.51% |
| 2021 Q2 | 15.43 Million USD | 61.98% |
| 2021 Q1 | 9.53 Million USD | 5315.34% |
| 2021 Q4 | 11.55 Million USD | 150.48% |
| 2021 Q3 | -22.88 Million USD | -248.22% |
| 2020 Q4 | 176 Thousand USD | -82.08% |
| 2020 FY | - USD | 42.26% |
| 2020 Q3 | 982 Thousand USD | 104.95% |
| 2020 Q1 | -12.72 Million USD | -9.11% |
| 2020 Q2 | -19.82 Million USD | -55.87% |
| 2019 Q4 | -11.65 Million USD | 16.18% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | -13.9 Million USD | -16.95% |
| 2019 Q2 | -11.89 Million USD | -3457.2% |
| 2019 Q1 | 354.25 Thousand CAD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Filament Health Corp. | -4.66 Million CAD | -998.656% |